Continued Improvement in Pressure-Flow Parameters in Men Receiving Finasteride for 2 Years

August 1999 in “ Urology ”

Wolfgang Schäfer, Teuvo L.J. Tammela, Diane M. Barrett, Paul Abrams, Hans Hedlund, H.J. Rollema, Jørgen Nordling, Johannes Andersen, Tage Hald, A. Matos-Ferriera, Reginald C. Bruskewitz, P.D. Miller, S. Mustonen, A. Cannon, Marie-Pierre Malice, Carol A. Jacobsen, Mark A. Bach

finasteride Propecia

Studysummary This study found that finasteride improved urodynamic measures of obstruction in men with benign prostatic enlargement and lower urinary tract symptoms, with continued improvement over two years of treatment.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on linkinghub.elsevier.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

1054 citations , February 1998 in “The New England Journal of Medicine”

In this study, men with benign prostatic hyperplasia who took finasteride for four years experienced reduced urinary symptoms, fewer surgeries, less acute urinary retention, increased urinary flow rates, and decreased prostate volume.

research The Clinical Development of a 5α-Reductase Inhibitor, Finasteride

211 citations , November 1990 in “The Journal of Steroid Biochemistry and Molecular Biology”

Finasteride effectively treats BPH, but needs more trials to understand potential.